Concepedia

Aristo Muktabar

AM

Statistics

Publications

4

Citations

133

H-Index

4

Active since

2018

Affiliations

Nanyang Technological University(Current)

The Ohio State University

Harvard University

Aristo Muktabar is an author at Nanyang Technological University specializing in pharmacology, pharmacy, and drug delivery.

ORCID

Publications per year

2018–2021

4

Publications

4

Liposomal Nanotherapy for Treatment of Atherosclerosis

Anastasia Darwitan, Yee Shan Wong, Luong T. H. Nguyen et al. · Advanced Healthcare Materials · 2020 · 48 citations

, , +17

Liposome interaction with macrophages and foam cells for atherosclerosis treatment: effects of size, surface charge and lipid composition

Jinkai Tang, Moumita Rakshit, Huei Min Chua et al. · Nanotechnology · 2021 · 31 citations · Full text

, , +17

Anti-inflammatory potential of simvastatin loaded nanoliposomes in 2D and 3D foam cell models

Moumita Rakshit, Anastasia Darwitan, Aristo Muktabar et al. · Nanomedicine Nanotechnology Biology and Medicine · 2021 · 28 citations · Full text

, , +14

The Potential of Fluocinolone Acetonide to Mitigate Inflammation and Lipid Accumulation in 2D and 3D Foam Cell Cultures

Luong T. H. Nguyen, Aristo Muktabar, Jinkai Tang et al. · BioMed Research International · 2018 · 26 citations · Full text

, , +17

1–4 of 4